1-4 of 4
Byung Min Ahn, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

Yee Soo Chae, MD, Sang Kyun Sohn, MD, PhD, Jong Gwang Kim, MD, PhD, Yoon Young Cho, MD, Joon Ho Moon, MD, Byung Min Ahn, MD, Shi Nae Kim, MD
Journal: Blood
Blood (2007) 110 (11): 4258.
https://doi.org/10.1182/blood.V110.11.4258.4258
Published: 2007
Journal Articles

The Impact of Alemtuzumab as a Component of Conditioning Regimens on Transplantation Outcomes in a Setting of CMV-Seropositive Recipient and Donor.

Byung Min Ahn, MD, Sang Kyun Sohn, M.D., Jong Kwang Kim, M.D., Yee Soo Chae, M.D., Yoon Young Cho, M.D., Joon Ho Moon, M.D., Deok Hwan Yang, M.D., Je-Jung Lee, M.D., Yeo-Kyeoung Kim, M.D., Hyeoung-Joon Kim, M.D.
Journal: Blood
Blood (2006) 108 (11): 5270.
https://doi.org/10.1182/blood.V108.11.5270.5270
Published: 2006
Journal Articles

Risk Factors for Predicting CMV Infection in Allogeneic-PBSCT Setting: MNC Dose, Campath Use, and Acute GVHD Grade ≥II.

Byung Min Ahn, MD, Joon Ho Moon, M.D., Yoon Young Cho, M.D., Yee Soo Chae, M.D., Jong Gwang Kim, M.D., Sang Kyun Sohn, M.D.
Journal: Blood
Blood (2006) 108 (11): 5298.
https://doi.org/10.1182/blood.V108.11.5298.5298
Published: 2006
Journal Articles

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

Sang Kyun Sohn, MD, Yoon Young Cho, MD, Byung Min Ahn, MD, Yee Soo Chae, MD, Jong Gwang Kim, MD, Joon Ho Moon, MD
Journal: Blood
Blood (2006) 108 (11): 4762.
https://doi.org/10.1182/blood.V108.11.4762.4762
Published: 2006